Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease

Reference

• Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007; 130:223 - 33; http://dx.doi.org/10.1016/j.cell.2007.07.003; PMID: 17662938
   PubMed Web of Science ®Google Scholar
• Campisi J, d’Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8:729 - 40; http://dx.doi.org/10.1038/nrm2233; PMID: 17667954
   PubMed Web of Science ®Google Scholar
• Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005; 37:961 - 76; http://dx.doi.org/10.1016/j.biocel.2004.10.013; PMID: 15743671
   PubMed Web of Science ®Google Scholar
• Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, Dixon JB, Weltman MD, Tilg H, Moschen AR, et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007; 133:80 - 90; http://dx.doi.org/10.1053/j.gastro.2007.05.012; PMID: 17631134
   PubMed Web of Science ®Google Scholar
• Nakajima T, Moriguchi M, Katagishi T, Sekoguchi S, Nishikawa T, Takashima H, Kimura H, Minami M, Itoh Y, Kagawa K, et al. Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD. Liver Int 2006; 26:23 - 31; http://dx.doi.org/10.1111/j.1478-3231.2005.01178.x; PMID: 16420506
   PubMed Web of Science ®Google Scholar
• Nakajima T, Nakashima T, Okada Y, Jo M, Nishikawa T, Mitsumoto Y, Katagishi T, Kimura H, Itoh Y, Kagawa K, et al. Nuclear size measurement is a simple method for the assessment of hepatocellular aging in non-alcoholic fatty liver disease: Comparison with telomere-specific quantitative FISH and p21 immunohistochemistry. Pathol Int 2010; 60:175 - 83; http://dx.doi.org/10.1111/j.1440-1827.2009.02504.x; PMID: 20403043
   PubMed Web of Science ®Google Scholar
• Sasaki M, Ikeda H, Yamaguchi J, Miyakoshi M, Sato Y, Nakanuma Y. Bile ductular cells undergoing cellular senescence increase in chronic liver diseases along with fibrous progression. Am J Clin Pathol 2010; 133:212 - 23; http://dx.doi.org/10.1309/AJCPWMX47TREYWZG; PMID: 20093230
   PubMed Web of Science ®Google Scholar
• Sasaki M, Ikeda H, Yamaguchi J, Nakada S, Nakanuma Y. Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence. Hepatology 2008; 48:186 - 95; http://dx.doi.org/10.1002/hep.22348; PMID: 18536059
   PubMed Web of Science ®Google Scholar
• Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134:657 - 67; http://dx.doi.org/10.1016/j.cell.2008.06.049; PMID: 18724938
   PubMed Web of Science ®Google Scholar
• Marshall A, Rushbrook S, Davies SE, Morris LS, Scott IS, Vowler SL, Coleman N, Alexander G. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 2005; 128:33 - 42; http://dx.doi.org/10.1053/j.gastro.2004.09.076; PMID: 15633121
   PubMed Web of Science ®Google Scholar
• Aravinthan A, Scarpini C, Tachtatzis P, Verma S, Penrhyn-Lowe S, Harvey R, Davies SE, Allison M, Coleman N, Alexander G. Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. J Hepatol 2013; 58:549 - 56; http://dx.doi.org/10.1016/j.jhep.2012.10.031; PMID: 23142622
   PubMed Web of Science ®Google Scholar
• Aravinthan A, Pietrosi G, Hoare M, Jupp J, Marshall A, Verrill C, Davies S, Bateman A, Sheron N, Allison M, et al. Hepatocyte expression of the senescence marker p21 is linked to fibrosis and an adverse liver-related outcome in alcohol-related liver disease. PLoS One 2013; 8:e72904; http://dx.doi.org/10.1371/journal.pone.0072904; PMID: 24086266
   PubMed Web of Science ®Google Scholar
• Kong X, Feng D, Wang H, Hong F, Bertola A, Wang FS, Gao B. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 2012; 56:1150 - 9; http://dx.doi.org/10.1002/hep.25744; PMID: 22473749
   PubMed Web of Science ®Google Scholar
• Klein S, Klösel J, Schierwagen R, Körner C, Granzow M, Huss S, Mazar IG, Weber S, van den Ven PF, Pieper-Fürst U, et al. Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats. Lab Invest 2012; 92:1440 - 50; http://dx.doi.org/10.1038/labinvest.2012.106; PMID: 22890553
   PubMed Web of Science ®Google Scholar
• Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28:339 - 50; http://dx.doi.org/10.1055/s-0028-1091978; PMID: 18956290
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37:1202 - 19; http://dx.doi.org/10.1053/jhep.2003.50193; PMID: 12717402
   PubMed Web of Science ®Google Scholar
• de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008; 48:Suppl 1 S104 - 12; http://dx.doi.org/10.1016/j.jhep.2008.01.009; PMID: 18304679
   PubMed Web of Science ®Google Scholar
• Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 2013; 10:330 - 44; http://dx.doi.org/10.1038/nrgastro.2013.41; PMID: 23507799
   PubMed Web of Science ®Google Scholar
• Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30:1356 - 62; http://dx.doi.org/10.1002/hep.510300604; PMID: 10573511
   PubMed Web of Science ®Google Scholar
• Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121:91 - 100; http://dx.doi.org/10.1053/gast.2001.25540; PMID: 11438497
   PubMed Web of Science ®Google Scholar
• Anstee QM, Daly AK, Day CP. Genetics of alcoholic and nonalcoholic fatty liver disease. Semin Liver Dis 2011; 31:128 - 46; http://dx.doi.org/10.1055/s-0031-1276643; PMID: 21538280
   PubMed Web of Science ®Google Scholar
• Anstee QM, Goldin RD. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 2006; 87:1 - 16; http://dx.doi.org/10.1111/j.0959-9673.2006.00465.x; PMID: 16436109
   PubMed Web of Science ®Google Scholar
• Dongiovanni P, Valenti L, Rametta R, Daly AK, Nobili V, Mozzi E, Leathart JB, Pietrobattista A, Burt AD, Maggioni M, et al. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. Gut 2010; 59:267 - 73; http://dx.doi.org/10.1136/gut.2009.190801; PMID: 20176643
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007; 45:1366 - 74; http://dx.doi.org/10.1002/hep.21655; PMID: 17476695
   PubMed Web of Science ®Google Scholar
• Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ, Nash CRN, NASH CRN. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010; 52:894 - 903; http://dx.doi.org/10.1002/hep.23759; PMID: 20684021
   PubMed Web of Science ®Google Scholar
• Chalasani N, Guo X, Loomba R, Goodarzi MO, Haritunians T, Kwon S, Cui J, Taylor KD, Wilson L, Cummings OW, et al, Nonalcoholic Steatohepatitis Clinical Research Network. Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. Gastroenterology 2010; 139:1567 - 76, e1-6; http://dx.doi.org/10.1053/j.gastro.2010.07.057; PMID: 20708005
   PubMed Web of Science ®Google Scholar
• Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, et al. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51:1209 - 17; http://dx.doi.org/10.1002/hep.23622; PMID: 20373368
   PubMed Web of Science ®Google Scholar
• Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JB, Dongiovanni P, Patch J, Fracanzani A, Fargion S, Day CP, et al. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. J Hepatol 2012; 56:448 - 54; http://dx.doi.org/10.1016/j.jhep.2011.05.029; PMID: 21756849
   PubMed Web of Science ®Google Scholar
• Yoneda M, Hotta K, Nozaki Y, Endo H, Uchiyama T, Mawatari H, Iida H, Kato S, Fujita K, Takahashi H, et al. Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease. Liver Int 2009; 29:1078 - 85; http://dx.doi.org/10.1111/j.1478-3231.2009.01988.x; PMID: 19302184
   PubMed Web of Science ®Google Scholar
• Miele L, Beale G, Patman G, Nobili V, Leathart J, Grieco A, Abate M, Friedman SL, Narla G, Bugianesi E, et al. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology 2008; 135:282 - 91, e1; http://dx.doi.org/10.1053/j.gastro.2008.04.004; PMID: 18515091
   PubMed Web of Science ®Google Scholar
• Dixon JB, Bhathal PS, Jonsson JR, Dixon AF, Powell EE, O’Brien PE. Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol 2003; 39:967 - 71; http://dx.doi.org/10.1016/S0168-8278(03)00459-8; PMID: 14642613
   PubMed Web of Science ®Google Scholar
• Korthagen NM, van Moorsel CH, Barlo NP, Kazemier KM, Ruven HJ, Grutters JC. Association between variations in cell cycle genes and idiopathic pulmonary fibrosis. PLoS One 2012; 7:e30442; http://dx.doi.org/10.1371/journal.pone.0030442; PMID: 22291954
   PubMedGoogle Scholar
• Ma H, Chen J, Pan S, Dai J, Jin G, Hu Z, Shen H, Shu Y. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population. Lung Cancer 2011; 73:32 - 7; http://dx.doi.org/10.1016/j.lungcan.2010.11.001; PMID: 21145615
   PubMed Web of Science ®Google Scholar
• Kong EK, Chong WP, Wong WH, Lau CS, Chan TM, Ng PK, Song YQ, Mak W, Lau YL. p21 gene polymorphisms in systemic lupus erythematosus. Rheumatology (Oxford) 2007; 46:220 - 6; http://dx.doi.org/10.1093/rheumatology/kel210; PMID: 16837471
   PubMed Web of Science ®Google Scholar
• Davalos AR, Coppe JP, Campisi J, Desprez PY. Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev 2010; 29:273 - 83; http://dx.doi.org/10.1007/s10555-010-9220-9; PMID: 20390322
   PubMed Web of Science ®Google Scholar
• Tomita K, Teratani T, Suzuki T, Oshikawa T, Yokoyama H, Shimamura K, Nishiyama K, Mataki N, Irie R, Minamino T, et al. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice. J Hepatol 2012; 57:837 - 43; http://dx.doi.org/10.1016/j.jhep.2012.05.013; PMID: 22641095
   PubMed Web of Science ®Google Scholar
• Campisi J. The role of cellular senescence in skin aging. The journal of investigative dermatology Symposium proceedings / the Society for Investigative Dermatology, Inc [and] European Society for Dermatological Research 1998; 3:1-5.
   Google Scholar
• Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94:2467 - 74; http://dx.doi.org/10.1111/j.1572-0241.1999.01377.x; PMID: 10484010
   PubMed Web of Science ®Google Scholar
• Daly AK, Fairbrother KS, Andreassen OA, London SJ, Idle JR, Steen VM. Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype. Pharmacogenetics 1996; 6:319 - 28; http://dx.doi.org/10.1097/00008571-199608000-00005; PMID: 8873218
   PubMedGoogle Scholar